Alexandria Real Estate Equities, Inc. (ARE) Q3 2026 earnings review
Alexandria's leasing and asset sales pick up, but profit falls
Alexandria Real Estate Equities, an owner of life-science and technology campuses, eased its year-end funding crunch while its quarterly profit kept falling. Revenue dropped 11% from a year ago and funds from operations per share, excluding one-offs, fell 31% as interest costs rose and tenants shut down. By our math, the full-year outlook points to profit per share dropping another 9% from this quarter to $1.40 in the fourth quarter.
| Same-property cash net operating income | -2.8% from a year ago (-9.2% GAAP YTD) |
|---|---|
| FFO per share, excluding one-offs | $1.54 -31% from a year ago |
| Total leasing volume | 1.24M RSF +19% from last quarter (highest since 4Q24) |
| Full-year FFO per share outlook | Unchanged middle of the range: $6.40 (implies $1.40 in Q4) |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because progress on debt funding and leasing was offset by a warning that occupancy and property income will fall again in 2027. Issuing $1 billion of subordinated debt and closing the Campus Point joint venture took the pressure off this year's asset-sale plan, and vacant-space leasing hit its second-highest level ever. The bad news: Alexandria raised its 2026 tenant-failure loss estimate and warned that $101 million of 2027 lease expirations will keep same-property profit negative next year.
The question now is whether rising leasing volume can outrun next year's wave of move-outs and shrinking interest credits. If vacant-space leasing stays strong and pending asset sales close on time, earnings can stabilize in 2027; if biotech tenant failures continue and tech conversions bring lower rents, profit will step down again. Management's formal 2027 outlook at Investor Day on December 2 will give the first full numbers.
🐂 Bull Case
New Debt and Campus Point Sale Ease Funding Pressure
Alexandria Real Estate Equities, an owner of laboratory and tech campuses, entered the third quarter needing nearly $2.9 billion from property sales in five months to pay down debt. Management changed tack in August by issuing $1.0 billion of 30-year junior subordinated notes at a 7.25% interest rate. The landlord said the issuance "supports our liquidity, capital structure, and deleveraging objectives while receiving 50% equity treatment from key rating agencies".
- 2026 asset-sale target: cut by $1.0 billion to a $1.9 billion middle of the range
- Campus Point joint venture sale: $475 million for a 29% stake, closed in October
- Completed and pending sales: $2.62 billion, including $717 million closed and $1.90 billion under deposit or in late-stage talks
This financing matters because it removes the risk of forced property sales before year-end. Because pending deals now top the lower $1.9 billion target by $720 million, Alexandria can defer some sale proceeds into 2027 to fund next year's construction bills while keeping its year-end debt-to-earnings target of 5.6x to 6.2x.
What to watch: how much of the $1.55 billion in late-stage negotiations closes by December 31, 2026. Closing at least $1.2 billion of pending deals would bring leverage down from 6.6x into the target range without needing more high-cost debt.
Vacant Space Leasing Reached Its Second-Highest Level Ever
Demand at Alexandria's properties picked up in the third quarter. The company signed 1.24 million rentable square feet (RSF) of leases, its highest quarterly total since late 2024 and 19% above the second quarter. Existing tenants generated 74% of all leasing volume over the past twelve months, and year-to-date leases carry an average term of 10.9 years.
More importantly, Alexandria leased 450,961 RSF of previously vacant space, the second-highest quarterly figure in its history. That helped push operating occupancy up 0.2 percentage points from last quarter to 87.1%, while cash rent cuts on renewals narrowed to 3.3% from 4.3% in the second quarter. Still, the company projects fourth-quarter leasing to slow to around 1.01 million RSF.
What to watch: fourth-quarter leasing of vacant space and the backlog of signed leases awaiting move-in, which slipped from $69 million of annual rent to $52 million this quarter. If new vacant leasing does not replenish that backlog as tenants move in, occupancy will struggle to hold 87% next year.
Tech Pivot and Fenway Sale Cut Construction Bills
Alexandria has been reviewing stalled laboratory projects to cut future construction spending. This quarter it resolved two major sites in Massachusetts. At 311 Arsenal Street, the landlord signed 66,859 RSF of leases and is negotiating another 100,684 RSF with technology tenants, allowing it to "pivot the redevelopment project to a lower-cost advanced technology use, reducing future potential construction spend by approximately $220 million".
At 421 Park Drive in Fenway, the company agreed to sell a 339,668 RSF development project to an institutional user, avoiding another $136 million of future construction costs. The trade-off is lower returns: Alexandria noted that the Arsenal Street tech pivot comes "at lower rental rates and stabilized yields than our initial underwriting", and moving the building into the operating pool lowered company-wide occupancy by 0.9 percentage points.
What to watch: the outcome for the three remaining redevelopment projects covering 667,002 RSF still under review. Converting or selling those sites before year-end would lock in lower 2027 construction spending.
🐻 Bear Case
Ending Project Interest Credits Drove Borrowing Costs Up 45%
Accounting rules let a landlord capitalize — add to a building's balance-sheet cost rather than expense on the income statement — the interest and property taxes on projects under active development. Once construction finishes or stops because a property is put up for sale, those costs hit quarterly profit immediately.
Because Alexandria delivered a Waltham project and marked developments in Fenway and Stanford for sale, its average real estate balance eligible for interest capitalization fell to $5.87 billion in the third quarter from $6.94 billion in the first half, and ended September at $4.46 billion. As a result, interest expense jumped 45.3% from a year ago to $79.7 million, rising 4.6 percentage points as a share of revenue. That pushed funds from operations (FFO) per share, excluding one-offs, down 30.6% from a year ago to $1.54.
What to watch: fourth-quarter interest expense and the capitalized property basis, which the outlook puts at $3.4 billion to $4.9 billion. Management expects full-year interest expense near the $300 million top of its plan, which by our math means up to $91 million in the fourth quarter.
Occupancy and Same-Property Profit Will Fall Again in 2027
Alexandria highlights steady leasing progress, yet its first preliminary framework for 2027 points to another year of shrinking property income. For 2027, the company expects average operating occupancy to "temporarily decline relative to our projected operating occupancy as of December 31, 2026" and warns that same-property net operating income will remain negative for a third straight year.
- 2027 key lease expirations: 1.38 million RSF ($100.5 million of annual rent) expiring around March 2027, with 9 to 24 months of downtime
- 2026 tenant wind-down drag: raised by $5 million to $30–35 million of FFO ($16 million recognized in Q3 alone)
- 2027 tenant wind-downs: Alexandria said it will "preliminarily estimate at least a similar level of reduction in funds from operations may be necessary in 2027"
This cuts against the idea that fourth-quarter 2026 marks the bottom for operations. While signed leases awaiting move-in will add $52 million of annual rent by mid-2027, known 2027 move-outs ($100.5 million), another $30 million or more of tenant failures, and the loss of $11 million in annual development fees outweigh the incoming rent.
What to watch: formal 2027 FFO per share and occupancy targets at Investor Day on December 2, 2026. If the 2027 outlook shows FFO per share falling below the $5.60 annualized fourth-quarter pace, earnings have not yet reached a floor.
Selling Unwanted Properties Triggered $638 Million in Write-Downs
When Alexandria decides to sell land or older buildings outside its main campuses rather than spend money converting them into laboratories, it has to mark their book value down to what buyers will pay today. In the third quarter, the landlord recorded $637.9 million of real estate impairment charges on properties held for sale, bringing nine-month write-downs to $865.9 million.
The largest write-downs hit the Fenway development project ($343.3 million) and ten office and operating buildings in Palo Alto and San Carlos ($214.5 million combined). In July, the company also sold two Palo Alto properties for $163 million because "due to the project’s macroeconomic outlook, the assets no longer aligned with our strategy and were sold to a residential developer". Selling lab land for housing and office use shows that excess life-science real estate is worth far less than its carrying cost.
What to watch: additional impairment charges in the fourth quarter as the remaining $1.55 billion of negotiated sales reach binding contracts. Further write-downs will shrink book equity even if FFO excludes them.
Risks This Quarter Didn't Answer
Three standing risks — regulatory and competitive pressures on biotech tenants, a legal dispute in New York, and whether the third-quarter profit beat signals better underlying demand — were not settled by the earnings release.
- Biotech regulation and AI: Alexandria argued in its slides that artificial intelligence does not replace physical lab work and noted 37 FDA novel drug approvals through September, but public biotech tenants still made up only 12% of third-quarter leasing; watch 2027 biotech leasing share.
- New York City ground lease dispute: the release gave no update on the landlord default notice and option-parcel litigation at the New York campus; the third-quarter Form 10-Q legal footnote will show if the appeal progressed.
- Third-quarter FFO beat vs implied plan: FFO per share of $1.54 beat the $1.49 middle of the range implied by our math, but only because property sales closed later in the year, keeping full-year FFO unchanged at $6.40.
💲 Other KPIs
Total debt fell 5.1% from a year ago and increased by $84 million from last quarter, by our math. Alexandria used proceeds from its $1.0 billion subordinated note offering to pay down $903 million on its credit line and commercial paper program, leaving $1.09 billion drawn, and extended its $5.0 billion credit line maturity to 2032.
Overhead costs rose 40.0% from a year ago and 11.0% from last quarter, climbing from 3.9% of revenue a year ago to 6.1% by our math. Expense levels have stepped up for three straight quarters as temporary cost cuts made in 2025 expired, though trailing twelve-month overhead remains 7.5% of net operating income.
The carrying value of Alexandria's venture capital stakes in life-science companies rose 12.9% from a year ago and 3.0% from last quarter. The portfolio generated $24.0 million of third-quarter income, consisting of $16.0 million in realized cash gains, $21.6 million in paper gains, and $13.6 million of write-offs on private holdings.
🔮 Guidance
Unchanged at the middle of the range. The plan still calls for $6.40 per share, down 29.0% from 2025, while narrowing the band by 6 cents. By our math, subtracting $5.00 earned in the first nine months leaves $1.40 for the fourth quarter, down 9.1% from the third quarter and 35.2% from a year ago. Alexandria has held the $6.40 midpoint across all four updates this year.
Unchanged. Management still targets year-end debt at 5.6 to 6.2 times annualized fourth-quarter earnings, down from 6.9x in the third quarter (or 6.6x after counting October's Campus Point sale). Hitting the 5.9x middle of the range depends on closing pending property sales in November and December to pay off the remaining $1.09 billion credit-line and commercial paper balance.
Cut. The landlord lowered its fourth-quarter target for how many times cash flow covers interest bills by 0.2x at the middle of the range, to 3.65x. The reduction reflects higher interest costs after issuing $1.0 billion of 7.25% junior subordinated notes in August instead of relying solely on property sales.
Unchanged. The outlook still expects $525 million at the middle of the range in operating cash retained after paying common dividends and joint-venture distributions. Having cut the quarterly dividend from $1.32 to $0.72 late last year, the company paid out only 47% of third-quarter funds from operations.
Cut. Alexandria lowered its full-year asset-sale target by $1.0 billion to a $1.90 billion middle of the range because the August subordinated note offering replaced $1.0 billion of needed proceeds. With $717 million closed by late October and $1.90 billion pending, total identified deals of $2.62 billion top the new midpoint, with excess closings scheduled for average completion in November.
Unchanged. Full-year capital spending remains at a $1.75 billion middle of the range, alongside a $675 million target for net unsecured debt reduction (cut from $1.675 billion after counting the $1.0 billion subordinated notes). Management plans to reduce construction spending again in 2027 and 2028 as active developments wrap up.
Unchanged. The year-end target stays at an 87.0% middle of the range, essentially in line with September's 87.1% reading and down from 90.9% at the end of 2025. Moving 311 Arsenal Street into the operating pool cut third-quarter occupancy by 0.9 percentage points, while moving vacant properties into held-for-sale added 0.6 points.
Unchanged. Both GAAP and cash same-property net operating income are still projected to fall 9.5% at the middle of the range. Because nine-month GAAP same-property profit is down 9.2% and cash is down 8.4%, by our math the plan points to roughly a 10.4% GAAP drop and a 12.8% cash drop in the fourth quarter.
Unchanged. Full-year renewal rent changes remain at a -5.0% GAAP and -11.0% cash middle of the range. Through the first nine months, GAAP renewal rates are down 5.1% and cash rates are down 6.9%, sitting well above the cash midpoint after third-quarter cash spreads improved to -3.3%.
Cut. The middle of the range fell by $5 million to $55 million, after a $10 million cut last quarter. The reduction comes from writing off deferred rent balances for struggling tenants; Alexandria raised its full-year estimate for tenant wind-down losses to $30–35 million, having already booked $30 million through September.
Unchanged. Full-year overhead remains at a $144 million middle of the range. With $112.5 million spent in the first nine months, by our math the outlook leaves $31.5 million for the fourth quarter, down from $40.9 million in the third quarter.
Unchanged. Full-year capitalized interest stays at a $240 million middle of the range, with the fourth-quarter capitalized real estate basis projected at $3.4 billion to $4.9 billion, down from $5.87 billion in the third quarter.
Unchanged in range, but guided to the top end. While the $280 million middle of the range did not move after two prior raises (+$5M in Q1, +$20M in Q2), management now expects full-year interest expense near $300 million due to the August subordinated note offering. By our math, the $300 million top end leaves $91.4 million of interest expense for the fourth quarter, up from $79.7 million in Q3.
Cut. Alexandria lowered the middle of the range by $10 million to $65 million because several venture-portfolio exits previously expected to close in late 2026 were pushed into 2027. Through September, the company has booked $44.5 million of realized gains ($28.5 million in the first half plus $16.0 million in Q3).
❓ Key Questions
What cap rate attaches to the $1.9 billion pending sales?
Alexandria disclosed that third-quarter sales of $234 million carried $4.4 million of annual net operating income and the $475 million Campus Point stake pays a 5.5% initial yield, but gave no income figure for the $1.90 billion of pending deals.
How much lower are yields on the Arsenal tech pivot?
Management said pivoting 311 Arsenal Street to advanced technology saves $220 million of construction spend but brings lower rents and yields than laboratory space. Investors need the new stabilized yield compared with the original lab plan.
How much of the 2027 expiring space has early renewals?
The 2027 key expiration list remains at 1.38 million RSF and $100.5 million of annual rent, with downtime estimated at 9 to 24 months. Management has not said how much of that space is in active renewal or re-leasing talks.
What is the status of the New York lease dispute?
Last quarter's filing detailed a ground-lease default notice and court rulings at the New York City campus, which generates about $65 million of annual rent. The third-quarter release did not mention the dispute.